COVID-19 Global Targets and Progress Tracker

The COVID-19 Global Targets and Progress Tracker presents a consolidated view of the progress towards global COVID-19 targets, barriers in access to COVID-19 tools, and delivery of donor pledges. The global targets presented in the Tracker are based on an alignment of the targets identified in the IMF Pandemic Proposal, ACT-A Strategic Plan & Budget, and the US-hosted Global C19 Summit, and as such have been reaffirmed by multilateral institutions and global leaders. We will continue to enhance the tracker as we improve our data collection efforts.

Targets and Overview of Progress

Alignment of Targets

Overview of Gaps

		LIC	LMIC	UMIC	HIC	World
Vaccines
Secure Vaccines to Cover 70% of the Population	%. of Countries with Procurement Gap	78	29	25	2	27
Secure Vaccines to Cover 70% of the Population	Gap (Mn Doses)	113	180	46	0	338
Diagnostics
Test Over 1/1000 population per day	%. of Countries Not on Track	100	73	63	59	56
Test Over 1/1000 population per day	Gap (Mn Tests Daily)	0.64	6.49	4.2	0.11	11.43
Sequence > 1% of COVID Cases	%. of Countries Not on Track	65	69	82	26	49
Treatment / PPE
Oxygen Shortages	%. of Countries on Oxygen Crisis Risk List	0	16	9	0	7
Identified Funding Needs (% of Countries)	COVID-19 PCR Diagnostic Tests	89	84	49	0	49
Identified Funding Needs (% of Countries)	COVID-19 RDT Diagnostic Tests	70	65	35	0	38
Identified Funding Needs (% of Countries)	COVID-19 PPE	81	82	53	0	49
Identified Funding Needs (% of Countries)	COVID-19 Therapeutics - Oxygen	89	78	45	0	47
Identified Funding Needs (% of Countries)	COVID-19 Therapeutics - Other	85	71	36	0	42

Last Update: 5 May 2022

1. Vaccines

The vaccination targets are to achieve at least 40% coverage in all countries by the end-2021 and 70% by mid-2022. Vaccines are the most effective tool to prevent severe disease and death, and lower transmission.

A. Secured/Expected Supply

Secured Vaccine Supply Target ≥ 70% of Population

B. End-2021 Vaccination Rate

C. Mid-2022 Vaccine Supply

Countries on Track to Reach 70% Vaccine Coverage in Administered Courses by Mid-2022

Sources: COVID-19 Vaccine Delivery Partnership Information Hub; WHO, UNICEF. Last Update: 5 May 2022. Country borders or names do not necessarily reflect the IMF’s official position.

D. COVAX and AVAT Deliveries

Sources and Notes: COVAX, UNICEF, Africa CDC, IMF staff calculations. Committed doses are doses that the COVAX facility is required to procure. Support from e US has allowed COVAX to secure 1b Pfizer doses. These include a donation of 700m doses, and the rest 300m doses is treated as non-donations. However, for this presentation all 1b facilitated doses are included in the Pfizer category. The secured supply agreement numbers for SII-AstraZeneca and SII-Novavax are approximated based on COVAX Facility candidate-specific supply information. The dose donations are based on COVAX estimates based on commitments from donors to share doses bilaterally with the COVAX facility.

Last Update: 5 May 2022.

E. Vaccines Administered

At least one dose

Fully vaccinated

F. Vaccination Speed Needed

2. Diagnostics

The diagnostics target is for all countries to achieve testing rates of 1 per 1,000 people per day by the end of 2021 / in 2022. Testing is needed to identify disease hotspots and track the emergence of new, dangerous variants.

A. Testing

Target = Daily Tests > 1 per 1000 people

B. Positivity Testing Rate

C. Detection of Variants

Improve the detection, monitoring, and mitigation of new COVID-19 variants

D. Capacity for Surveillance

Improve Capacity for Genomic Surveillance

3. Treatments & PPE

Treatments, including medical oxygen, are needed for those severely affected by COVID-19 or to prevent those in at-risk groups from progressing to severe disease.